567
Views
7
CrossRef citations to date
0
Altmetric
Editorial

When autologous chromatin becomes a foe

&
Pages 565-567 | Received 29 Jun 2012, Accepted 30 Jul 2012, Published online: 17 Sep 2012
 

Abstract

Apoptotic cells are recognized and cleared by the innate immune system. This process severely influences the outcome of several important functions of the latter. Apoptotic cells serve as sources for autoantigens employed by immature dendritic cells to maintain tolerance, excellent to prevent autoimmune diseases disastrous when this causes tumor tolerance. Apoptotic cells orchestrate healing and repopulation of the tissues, in which they died, again advantageous during wound healing and in the resolution phase of infections but a disaster after tumor reducing therapies. Many highly pathogenic microorganisms and viruses mimic changes of apoptotic cells like exposure of phosphatidyl serine and abuse their immune silencing signals to escape immune detection and eradication. If autologous chromatin is not properly cleared it is misinterpreted by the immune system as virus and causes the secretion by phagocytes of type-1 interferons. The continuous presence of these cytokines challenges tolerance and leads to SLE-like autoimmunity.

Declaration of interest : The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.